Groupe de Recherche et d’Action pour la Santé
Accueil > Solidarité Nord/Sud > Novartis vs. India : fin des auditions devant la Cour Suprême indienne (...)

Novartis vs. India : fin des auditions devant la Cour Suprême indienne (MSF)

jeudi 6 décembre 2012

"After 12 weeks of hearings in India’s Supreme Court, Médecins Sans Frontières (MSF) has learnt that final arguments into the Novartis vs. Union of India case challenging the interpretation of Section 3d of India’s patent law have today come to an end. During the hearings, which started on 11 September, the two judges presiding over the case heard arguments from Novartis as to why they deserved a patent on the mesylate salt of the blood and intestinal cancer drug imatinib. In recent weeks, the judges heard the counsel for the Indian government, and then representatives for the Cancer Patient Aid Association on arguments to defend India’s stricter patentability criteria that discourages patenting of new forms of known medicines..."

Voir en ligne : Novartis vs. India : Supreme Court hearing ends

SPIP | squelette | | Plan du site | Suivre la vie du site RSS 2.0 | © GRAS asbl 2012